Althea - tAckLing menTal Health cancer patients and their families: digital solutions for bEtter cAre
As of 2020, the World Health Organization (WHO) reported cancer as the world's second-leading cause of death, impacting patients across age groups and vulnerable subjects. Psychological issues like anxiety, depression, emotional distress, fear of recurrence, and cognitive impairment are prevalent among cancer patients and their carers, affecting treatment adherence. Digital systems, due to their cost-effectiveness and accessibility, play a vital role in improving patient well-being and engagement in their cancer journey while mitigating geographical barriers. In this line, this project aims to develop and implement the web-based Althea platform that would facilitate the screening of mental health issues among cancer patients and their families while supporting healthcare providers in accessing up-to-date educational materials and delivering tailored psychological support. The Althea solutions will provide systematic screening for psychological and cognitive impairment, and promote their access to informational material and targeted psychological support.
Specifically, the Althea platform will trigger systematic screening of the mental health status of pediatric, adolescent, adult cancer patients, their caregivers, and family members, timely identifying individuals at high level of risk to develop mental health issues. Additionally, the Althea system will equip healthcare providers with the necessary tools and resources ensuring timely and accurate identification of potential mental health issues and fostering referral to personalized mental health support for patients and their caregivers throughout their cancer journey. The creation and deployment of scalable, accessible, and personalized solutions for the screening and provision of psychological support to cancer patients and their families stand as a pivotal component within the domain of public health, carrying substantial socioeconomic ramifications.
Project details
Scientific responsability: Luigi Grassi
Funding source: EU4Health
Call: EU4H-2023-PJ
Start date 01/09/2024 - end date 31/08/2027
EU contribution: 3.357.199,84 €
EU contribution to UniFe: 39.403,00 €
Participants
- Istituto Europeo di Oncologia Srl, Italy - Coordinator
- Institut Catala d'Oncologia, Spain
- Universitat des Saarlandes, Germany
- Unicancer, France
- Nacionalinis Vezio Institutas, Lithuania
- Idryma Technologias Kai Erevnas, Greece
- European Cancer Organisation, Belgium
- Universitaetsklinikum Hamburg-Eppendorf, Germany
- Universita degli Studi di Ferrara, Italy
- Medizinische Universitat Graz, Austria
- Universidad de Navarra, Spain
- European Organisation for Research and Treatment of Cancer AISBL, Belgium
- Technologiko Panepistimio Kyprou, Cyprus
- European Alliance for Personalised Medicine, Slovenia
- European Cancer Patient Coalition, Belgium
- Global Alliance of Mental Illness Advocacy Networks Europe AISBL, Belgium
- Childhood Cancer International, Netherlands
- Institute for Gastroenterological Tumors, Croatia
- Sdruzhenie Asotsiatsia na Patsientite S Onkologichni Zabolyavania I Priyateli, Bulgaria
- CF World Against Cancer, Ukraine
- State Institution National Scientific Center the M.D. Strazhesko Institute of Cardiology, Clinical and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine, Ukraine
- Univerza v Mariboru, Slovenia
- Scuola Europea di Oncologia Associazione, Italy
- Espen-La Societe Europeenne de Nutrition Clinique et Metabolisme ASBL, Luxembourg
- International Sport and Culture Association, Denmark
- Fundacio Privada per a la Recerca i la Docencia Sant Joan de Deu, Spain